COMMUNIQUÉS West-GlobeNewswire

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform
30/11/2025
November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – Royal Philips (NYSE [...]
Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision
30/11/2025
November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1] CE-marked, 510k pending [...]
DeepHealth Unveils Next-Generation Imaging Informatics and Clinical AI Solutions at RSNA 2025, Advancing a New Standard of AI-Powered Care
30/11/2025
Company expands portfolio of novel AI-powered clinical and operational solutions delivering proven impact at scale—empowering breakthroughs in care through imaging CHICAGO, Nov. 30, 2025 (GLOBE NEWSWIRE) -- DeepHealth, [...]
Konica Minolta Healthcare Launches New Floor-Mounted Digital Radiography Systems at RSNA 2025
30/11/2025
WAYNE, N.J. and CHICAGO, Nov. 30, 2025 (GLOBE NEWSWIRE) -- Today at the 2025 Annual Meeting of the Radiological Society of North America (RSNA), Konica Minolta Healthcare Americas, Inc., announced the new KDR FMT and [...]
At RSNA 2025, ASCEND Cardiovascular and Konica Minolta Healthcare Announce Partnership to Deliver a Best-in-Class Enterprise Imaging Solution that Elevates Cardiovascular Care
30/11/2025
WAYNE, N.J. and SPRINGFIELD, Ill., Nov. 30, 2025 (GLOBE NEWSWIRE) -- ASCEND Cardiovascular, a leading provider of purpose-built enterprise imaging for cardiology, and Konica Minolta Healthcare Americas, Inc., a world- [...]
Anabolic Steroids Alternatives: Muscle Building Supplements from CrazyBulk | Most Selling Muscular Endurance Supplements Bodybuilders Use For Peak Performance & Strength Building in 2025
29/11/2025
Discover how CrazyBulk’s Anabolic Steroids Alternatives supplements can enhance muscular endurance, boost strength, and speed up recovery. Learn optimal stacks, training integration tips, and where to buy authentic [...]
Algernon Closes Second Tranche of Private Placement Financing
29/11/2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) ( [...]
Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program
29/11/2025
VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
28/11/2025
ZUG, Switzerland, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a director of the Company. Attachment Notification of managers' [...]
INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”
28/11/2025
Acquisition advances INVO’s national expansion strategy, enhances its clinical capabilities, and broadens access to innovative fertility care across the Midwest SARASOTA, Fla. and INDIANAPOLIS, Nov. 28, 2025 (GLOBE [...]
PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference
28/11/2025
MENLO PARK, Calif., Nov. 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat [...]
NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update
28/11/2025
TORONTO and HAIFA, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a preclinical-stage biotechnology company pioneering exosome- [...]
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
28/11/2025
Extends cash runway through at least the first half of 2028 Led by Vivo Capital, Janus Henderson Investors, Coastlands Capital, Columbia Threadneedle Investments, Adage Capital Partners, and Squadron Capital Management [...]
Les Hôpitaux Shriners pour enfants Canada et l’Hôpital pour enfants du Centre des sciences de la santé de London lancent un programme de recherche historique pour faire progresser les soins liés aux maladies osseuses rares chez l’enfant
28/11/2025
Le premier anniversaire de l’affiliation des deux institutions est marqué par une expansion nationale de la recherche et des soins pour les enfants ayant des maladies complexes MONTRÉAL et LONDON, Ontario, 28 nov. 2025 [...]
Shriners Hospitals for Children Canada and Children’s Hospital at LHSC launch landmark research program to advance care in rare childhood bone disorders
28/11/2025
One-year anniversary of affiliation marked by national expansion in research and care for kids with complex conditions MONTREAL and LONDON, Ontario, Nov. 28, 2025 (GLOBE NEWSWIRE) -- One year after announcing a [...]
L’Agence des médicaments du Canada émet une recommandation positive pour le remboursement de SKYRIZI® (risankizumab) pour le traitement de la colite ulcéreuse, et AbbVie conclut une lettre d’intention avec l’Alliance pharmaceutique pancanadienne
28/11/2025
SKYRIZI ® , un inhibiteur de l’interleukine 23 (IL-23), a fait l’objet de deux recommandations consécutives de l’Agence des médicaments du Canada (AMC) visant son remboursement pour le traitement des maladies [...]
SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada’s Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance
28/11/2025
SKYRIZI ® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug Agency (CDA-AMC) for inflammatory bowel diseases, initially for Crohn’s disease (CD) and now [...]
Kane Biotech Announces Third Quarter 2025 Financial Results
28/11/2025
WINNIPEG, Manitoba, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced its third quarter 2025 financial results. Third Quarter 2025 Financial [...]
TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
28/11/2025
Fireside chat scheduled for Tuesday, December 2, 2025 at 12:30 PM ET NEW YORK, Nov. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and [...]

Pages